Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience

To the best of our knowledge, none of the prognostic staging systems for hepatocellular carcinoma (HCC) patients who underwent sorafenib therapy is universally adopted or preferred. In the present study, we aimed to compare prognostic ability among five prognostic systems, including the Japan Integr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: ENDO, MASATSUGU, NISHIKAWA, HIROKI, KITA, RYUICHI, KIMURA, TORU, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, SAITO, SUMIO, NISHIJIMA, NORIHIRO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, OSAKI, YUKIO
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812352/
https://ncbi.nlm.nih.gov/pubmed/27073653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.755
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars